On the afternoon of May 23, 2019, at 2:00 pm, leaders from the Food and Drug Administration of Jinan City and Tianqiao District visited Jinan Deheng Medical Technology Co., Ltd. for research work. Qi Desheng, the General Manager of Deheng Medical, and Yao Congcong, the R&D engineer, attended the research reception event.
Firstly, R&D engineer Yao Congcong gave a detailed report to the leaders on the current development status and prospects of the in vitro diagnostic reagent industry, as well as Deheng Medical's technological advantages, product content, and talent advantages. The leaders of the Food and Drug Administration highly affirmed the prospects of Deheng Medical Institute's in vitro diagnostic industry and quantum dot technology, and Yao Congcong also provided professional and detailed answers to the questions raised during the leadership's listening.
.jpg "5e1ffc94f3981(1).jpg")
Subsequently, General Manager Qi Desheng of Deheng Medical introduced the current development status and development plan of the enterprise to the leaders, and stated that although Deheng Medical has gone through ups and downs since its establishment, its original intention has not changed, and it has been forging ahead, leading Deheng colleagues to make their own achievements in the field of medical diagnosis.
Finally, the leaders of the Food and Drug Administration stated that this research activity has yielded great results. Not only have they gained a macro understanding of the in vitro diagnostic industry and quantum dot technology, but they have also gained a specific understanding of Deheng Medical's inflammation marker testing (PCT, CRP, SAA, IL-6, LP-PLA2), myocardial marker testing (CK-MB, D-Dimer, hs cTnI, MYO, NT proBNP, H-FABP), fluorescent immunostains, nasal allergen blocking sprays, and other products from the place of implementation. The medical diagnosis industry, as an important component of our city's high-tech industry, plays a great driving role in improving the level of medical diagnosis and medical services in our city. As a leading enterprise in the in vitro diagnostic industry in Jinan City, Deheng Medical should fully leverage its technological and talent advantages, further expand and strengthen the enterprise. The Food and Drug Administration and other relevant departments will also fully support the long-term development of innovative and technologically advanced enterprises like Deheng Medical in policy, injecting a continuous stream of vitality into the economic development and innovation of Jinan City.